A new synthetic approach to elvucitabine

Ling-yu Zhang , Yuan-yuan Lou , Gui-long Zhao , Lin-shan Zhang , Yan Chen

Chemical Research in Chinese Universities ›› 2013, Vol. 29 ›› Issue (1) : 57 -61.

PDF
Chemical Research in Chinese Universities ›› 2013, Vol. 29 ›› Issue (1) : 57 -61. DOI: 10.1007/s40242-013-2161-4
Article

A new synthetic approach to elvucitabine

Author information +
History +
PDF

Abstract

A new synthetic approach to elvucitabine started from L-xylose via the reactions of 10 steps in an overall yield of 20% was developed. The key steps included trimethylsilyl trifluoromethanesulfonate(TMSOTf)-mediated stereocontrolled β-glycosidation and exquisite choice of chloroacetyl group for the protection of hydroxyl groups as well as the corresponding deprotection under notably mild conditions. The structure of elvucitabine, in particular, the stereochemistry thereof, was unambiguously determined by comparison of the physical properties, such as 1H NMR data and the specific rotation, of the synthesized sample with those reported.

Keywords

Elvucitabine / Antiviral / Nucleoside analogue / Synthetic methodology

Cite this article

Download citation ▾
Ling-yu Zhang, Yuan-yuan Lou, Gui-long Zhao, Lin-shan Zhang, Yan Chen. A new synthetic approach to elvucitabine. Chemical Research in Chinese Universities, 2013, 29(1): 57-61 DOI:10.1007/s40242-013-2161-4

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Chen S. H., Lin S., King I., Spinka T., Dutschman G. E., Gullen E. A., Cheng Y. C., Doyle T. W. Bioorg. Med. Chem. Lett., 1998, 8(22): 3245.

[2]

Chen S. H., Li X., Li J., Niu C., Carmichael E., Doyle T. W. J. Org. Chem., 1997, 62(11): 3449.

[3]

Beach J. W., Kim H. O., Jeong L. S., Nampalli S., Islam Q., Ahn S. K., Babu J. R., Chu C. K. J. Org. Chem., 1992, 57(14): 3887.

[4]

Lin T. S., Luo M. Z., Liu M. C., Zhu Y. L., Gullen E., Dutschman G. E., Cheng Y. C. J. Med. Chem., 1996, 39(9): 1757.

[5]

Colucci P., Pottage J. C., Robison H., Turgeon J., Schürmann D., Hoepelman I. M., Ducharme M. P. Antimicrob. Agents Chemother., 2009, 53(2): 662.

[6]

Colucci P., Pottage J. C., Robison H., Turgeon J., Ducharme M. P. Antimicrob. Agents Chemother., 2009, 53(2): 646.

[7]

Wang X., Chang T. X., Zhang P., Chen Y., Liu X. Y. Chem. Res. Chinese Universities, 2012, 28(2): 334.

[8]

Shi J. X., McAtee J. J., Wirtz S. S., Tharnish P., Juodawlkis A., Liotta D. C., Schinazi R. F. J. Med. Chem., 1999, 42(5): 859.

[9]

Cook A. F., Maichuk D. T. J. Org. Chem., 1970, 35(6): 1940.

[10]

Naruto M., Ohno K., Naruse N., Takeuchi H. Tetrahedron Lett., 1979, 20(3): 251.

[11]

Johnson F., Starkovsky N. A., Paton A. C., Carlson A. A. J. Am. Chem. Soc., 1964, 86(1): 118.

[12]

Boeckel C. A. A., Beetz T. Tetrahedron Lett., 1983, 24(35): 3775.

[13]

Cambell A. S., Fraser-Reid B. J. Am. Chem. Soc., 1995, 117(41): 10387.

[14]

Udodong U. E., Rao C. S., Fraser-Reid B. Tetrahedron, 1992, 48(23): 4713.

[15]

Ngooi T. K., Scilimati A., Guo Z. W., Sih C. J. J. Org. Chem., 1989, 54(4): 911.

[16]

Schmidt U., Kroner M., Griesser H., Synthesis, 1991, 294.

[17]

McWilliams J. C., Clardy J. J. Am. Chem. Soc., 1994, 116(18): 8378.

[18]

Xu Y. C., Bizuneh A., Walker C. Tetrahedron Lett., 1996, 37(4): 455.

[19]

Baptistella L. H. B., Santos J. F. D., Ballabio K. C., Marsaioli A. J., Synthesis, 1989, 436.

[20]

Zhao G. L., Yu Z. Y., Li Y., Pang L. N., Wang J. W. Chin. J. Chem., 2008, 26(1): 158.

AI Summary AI Mindmap
PDF

99

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/